Please provide your email address to receive an email when new articles are posted on . Anti-Ro antibody positivity was linked to increased disease activity and more frequent glucocorticoid and ...
29d
F. Hoffmann-La Roche Ltd: FDA approves Roche's Gazyva/Gazyvaro for the treatment of lupus nephritis
FDA approval based on superiority of Gazyva/Gazyvaro over standard therapy alone, as shown in phase II NOBILITY and phase III REGENCY data1,2Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback